Ceapro Inc V.CZO

There was some very good news last week.

[captwade]

It was easy to miss though because it only lasted about 20 seconds.

For some years now we have listened to some of the most boring of presentations from this company.  We hear words like exciting, potential, helluva fantastic, masterpiece, and a new one last week, gem.  None of these words mean anything to a serious investor.  We were made aware of the huge markets that we eventually may get a piece of but were never given a clue as to what that could, in the end, mean for CZO. 

Last Wednesday we saw a small move in the right direction when Gagnon spoke, albeit briefly, about the net present value of a discounted future cash flow that a 3% share of the YBG market would mean to CZO.  He threw out a figure of $100,000,000. or about $1.30 per share.  I think this is what appears to have excited the market for our shares because the inferrence is that the current fair market value of CZO shares would be something over $2.00  { $1.30 plus the $.79 we are trading at. I repeat, fair market value TODAY.

Cheers all.

[Ciao]

I will need to listen to the presentation again to see if it was just for their current  BG or Y-BG, this is what I had previously noted: 1) NPV based on BG market alone gives CZO a value of $100 (using conservative 20% discount rate), this gives a NPV per share of $1.25 ($100M / 78 M shares o/s)

[Ciao]

I stand corrected, Gilles initially said BG, then indicated Y-BG at the 21:30 mark of the video. So an entry with 3% of market share does add about $100M to NPV or about $1.25 per share. That could be the incremental move in the share price. It all depends on the deal that is made. A 20% discount rate is very conservative as well. The fact that a calculation was made tells me they must have

[lscfa]

CZO mgmt must have learned a thing or two on how to pump from others....     Tetra expects $675M (U.S.) in QIXLEEF net sales by 2027   2020-12-07 08:46 ET - News Release   Dr. Guy Chamberland reports TETRA ESTIMATES NET SALES REACHING $675M USD BY 2027 TETRA IS EVALUATING POTENTIAL COMMERCIAL PARTNERS TO LAUNCH QIXLEEF IN USA Tetra Bio-Pharma Inc. has provided

[trek01]

Little advise for your well-being. Remove stocks you hate from your watchlists.

[boazklinghorn]

Interesting., but you know what they say.. :" Talk is cheap but it takes money to buy whiskey."